Provided by Tiger Trade Technology Pte. Ltd.

NEUROONE MEDICAL TECH

1.12
+0.04003.70%
Post-market: 1.120.00000.00%19:30 EDT
Volume:80.15K
Turnover:87.07K
Market Cap:10.20M
PE:-1.17
High:1.14
Open:1.07
Low:1.04
Close:1.08
52wk High:6.42
52wk Low:0.9615
Shares:9.11M
Float Shares:6.24M
Volume Ratio:0.23
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9571
EPS(LYR):-0.5387
ROE:-124.66%
ROA:-58.07%
PB:2.71
PE(LYR):-2.08

Loading ...

Neuroone Medical Technologies - Files Updated Prospectus Supplement for up to $13.4 Mln Atm Offering - SEC Filing

THOMSON REUTERS
·
Jun 13

NeuroOne Medical files prospectus for up to $13.4 million at-the-market stock offering

Reuters
·
Jun 13

NeuroOne Medical restates Q2 product revenue to USD 1.86 million after ASC 606 error

Reuters
·
Jun 13

Neuroone Medical Technologies Corp - Restatement Corrects $0.5 Mln Revenue Overstatement for Q1 2026 - SEC Filing

THOMSON REUTERS
·
May 23

NeuroOne restates March-quarter results after $0.5 million revenue overstatement

Reuters
·
May 23

NeuroOne Medical Tech Is Maintained at Buy by Ladenburg Thalmann

Dow Jones
·
May 14

Analysts Offer Insights on Healthcare Companies: DarioHealth (DRIO), NeuroOne Medical Technologies (NMTC) and COMPASS Pathways (CMPS)

TIPRANKS
·
May 14

NeuroOne Medical Tech Q2 EPS $(0.25) Misses $(0.23) Estimate, Sales $2.391M Miss $2.576M Estimate

Benzinga Earnings
·
May 12

NeuroOne Medical Technologies Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

NeuroOne FY26 Q2 net loss narrows to $2.1 million; product revenue rises 72% to $2.4 million

Reuters
·
May 12

NeuroOne Medical Technologies Corp expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 08

NeuroOne regains Nasdaq compliance after shares hold above $1 bid price

Reuters
·
May 04

NeuroOne COO Christopher Volker to become CFO as McClurg retires

Reuters
·
Apr 30

Neuroone Medical Technologies Corp - Ronald Mcclurg to Retire as CFO Effective June 30, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 30

U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings

Reuters
·
Apr 29

Neuroone Medical Technologies Corp : Jonestrading Adjusts Target Price to $8 From $1.5 to Reflect 1-for-6 Reverse Stock Split

THOMSON REUTERS
·
Apr 29

NeuroOne Medical Technologies trading halted, news pending

TIPRANKS
·
Apr 16

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Apr 16

Neuroone Medical Technologies Corp - Approves 1-for-6 Reverse Stock Split Effective April 15, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 14